Swiftscale Biologics
About:
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
Website: http://swiftscalebio.com
Top Investors: 8VC
Description:
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
Total Funding Amount:
$15M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
South San Francisco, California, United States
Founded Date:
2019-01-01
Founders:
David Mace, Matthew Delisa, Michael Jewett
Number of Employees:
11-50
Last Funding Date:
2020-06-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai